| Literature DB >> 28515427 |
Dan Huang1, Xuejuan Chen1, Xiaohan Zhang1, Yue Wang1, Hui Zhu1, Hui Ding2, Jing Bai2, Ji Chen2, Zhujun Fu3, Zijin Wang1, Hu Liu4.
Abstract
This study evaluated the performance of plusoptiX A12C in detecting amblyopia risk factors (ARFs) in Chinese children aged 3-to-4-year. PlusoptiX examination was successfully conducted among 1,766 subjects without cycloplegia to detect refractive error, asymmetry and media opacity. Cycloplegic retinoscopy (CR) was conducted on 357 children suspected of having vision abnormalities. Statistical differences between CR and the device were confirmed using the mean spherical value (+1.41 ± 0.87 D versus +1.14 ± 0.81 D), cylindrical value (-0.47 ± 0.64 versus -0.84 ± 0.78) and spherical equivalent (SE) value (+1.17 ± 0.84 D versus +0.72 ± 0.64 D) (all P < 0.0001). In the emmetropia group, the differences were statistically significant for the cylinder and SE (all P < 0.0001) but not the sphere (P = 0.33). In the hyperopia group, the differences were statistically significant for the sphere, cylinder and SE (all P < 0.0001). For refractive and strabismic ARFs detection, the sensitivity, specificity, positive predictive value, and negative predictive value were calculated, respectively.Entities:
Mesh:
Year: 2017 PMID: 28515427 PMCID: PMC5435680 DOI: 10.1038/s41598-017-02246-6
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Characteristics of Study Population.
| Number | % | |
|---|---|---|
| Total | 1818 | 100.00 |
| Gender | ||
| Male | 969 | 53.30 |
| Female | 849 | 46.70 |
| Testability | ||
| Testable | 1807 | 99.39 |
| Success | 1766 | 97.14 |
| Fail | 41 | 2.26 |
| Untestable | 11 | 0.61 |
Comparison between the plusoptiX and Cycloplegic Retinoscopy.
| Sphere (D) | Cylinder (D) | SE (D) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean | SD | 95% CI | P value* | Mean | SD | 95% CI | P value* | Mean | SD | 95% CI | P value* | |
| Total (N = 357) | ||||||||||||
| Cycloplegic Retinoscopy | 1.41 | 0.87 | 1.32–1.50 | N/A | −0.47 | 0.64 | −0.54–−0.41 | N/A | 1.17 | 0.84 | 1.08–1.26 | N/A |
| The plusoptiX | 1.14 | 0.81 | 1.06–1.22 | N/A | −0.84 | 0.78 | −0.92–−0.76 | N/A | 0.72 | 0.64 | 0.65–0.78 | N/A |
| Difference* | 0.27 | 0.95 | 0.17–0.37 | <0.0001 | 0.37 | 0.56 | 0.31–0.43 | <0.0001 | 0.45 | 0.86 | 0.37–0.54 | <0.001 |
| Myopia (N = 3) | ||||||||||||
| Cycloplegic Retinoscopy | −0.42 | 1.13 | −3.21–2.38 | N/A | −1.50 | 1.80 | −5.98–2.98 | N/A | −1.17 | 0.29 | −1.88–−0.45 | N/A |
| The plusoptiX | −0.33 | 1.61 | −4.33–3.66 | N/A | −1.67 | 1.15 | −4.54–1.20 | N/A | −1.17 | 1.04 | −3.75–1.42 | N/A |
| Difference* | −0.08 | 0.63 | −1.64–−1.48 | 0.84 | 0.17 | 0.76 | −1.73–2.06 | 0.74 | 0.00 | 0.87 | −2.15–2.15 | 1.00 |
| Emmetropia (N = 298) | ||||||||||||
| Cycloplegic Retinoscopy | 1.17 | 0.59 | 1.10–1.24 | N/A | −0.47 | 0.64 | −0.54–−0.40 | N/A | 0.94 | 0.54 | 0.88–1.00 | N/A |
| The plusoptiX | 1.13 | 0.78 | 1.04–1.22 | N/A | −0.86 | 0.80 | −0.95–−0.77 | N/A | 0.70 | 0.59 | 0.63–0.76 | N/A |
| Difference* | 0.05 | 0.81 | −0.05–0.14 | 0.33 | 0.39 | 0.56 | 0.33–0.45 | <0.0001 | 0.24 | 0.72 | 0.16–0.32 | <0.0001 |
| Hyperopia (N = 56) | ||||||||||||
| Cycloplegic Retinoscopy | 2.77 | 0.80 | 2.55–2.98 | N/A | −0.44 | 0.55 | −0.59–−0.30 | N/A | 2.55 | 0.69 | 2.36–2.73 | N/A |
| The plusoptiX | 1.29 | 0.82 | 1.07–1.51 | N/A | −0.72 | 0.62 | −0.89–−0.56 | N/A | 0.93 | 0.69 | 0.75–1.11 | N/A |
| Difference* | 1.48 | 0.68 | 1.30–1.66 | <0.0001 | 0.28 | 0.58 | 0.13–0.44 | <0.05 | 1.62 | 0.55 | 1.47–1.77 | <0.0001 |
SE, spherical equivalent; *Comparison between the Plusoptix A12C and cycloplegic retinoscopy; N/A, not applicable.
Figure 1Bland-Altman plots showing the agreement between the plusoptiX A12C and cycloplegia retinoscopy. (A) The difference of sphere. (B) The difference of cylinder. (C) The difference of spherical equivalent.
Accuracy for detecting refractive amblyopia risk factors.
| Age (month) | Myopia (D) | Hyper (D) | Astig (D) | Aniso (D) | Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) | |
|---|---|---|---|---|---|---|---|---|---|
| Manufacturer (sensitivity) | 30–50 | ≤−1.00 | ≥+1.00 | ≥1.00 | ≥1.00 | 100.00 | 49.57 | 7.45 | 100.00 |
| Matta/Silbert | 36–72 | ≤−1.00 | ≥+1.25 | ≥1.00 | ≥1.25 | 100.00 | 57.68 | 8.75 | 100.00 |
| AAPOS 2013 | 31–48 | <−3.00 | >+4.00 | >2.00 | >2.00 | 92.86 | 94.49 | 40.63 | 99.69 |
| ABCD 2012 | 8–72 | ≤−2.25 | ≥+2.50 | ≥2.25 | ≥1.00 | 100.00 | 90.72 | 30.43 | 100.00 |
| Manufacturer (specificity) | 36–72 | ≤−1.50 | ≥+2.50 | ≥1.50 | ≥1.00 | 100.00 | 82.03 | 18.42 | 100.00 |
PPV, positive predictive value; NPV, negative predictive value.
Accuracy for detecting strabismic amblyopia risk factors.
| Criteria | Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) |
|---|---|---|---|---|
| Asymmetry ≥5° | 100.00 | 96.11 | 5.48 | 100.00 |
| Asymmetry ≥10° | 25.00 | 99.83 | 25.00 | 99.83 |
PPV, positive predictive value; NPV, negativepredictive value.
Diagnosis of children who failed to be tested or were not tested.
| Diagnosis | Number | % |
|---|---|---|
| Abnormal | 20 | 38.46 |
| Amblyopia | 12 | 23.08 |
| Myopia <−3.0 D | 2 | 3.85 |
| Hyperopia >4.0 D | 7 | 13.46 |
| Astigmatism >2.0 D | 7 | 13.46 |
| Anisometropia >2.0 D | 6 | 11.54 |
| Persistent pupilary membrane | 2 | 3.85 |
| Strabismus | 4 | 7.69 |
| Normal | 32 | 61.54 |
| Total | 52 | 100.00 |